INTERNATIONAL PATENT: SUZHOU SHENTUO PHARMACEUTICAL TECHNOLOGY CO., LTD, 苏州申拓医药科技有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION CONTAINING TLR7/8 SELECTIVE AGONIST AND HBV CAPSID ASSEMBLY INHIBITOR AND USE THEREOF"

GENEVA, March 31 -- SUZHOU SHENTUO PHARMACEUTICAL TECHNOLOGY CO., LTD (2502-3, 25th Floor, Building 4, No. 209 Zhuyuan Road, High Tech ZoneSuzhou, Jiangsu 215011), 苏州申拓医药科技有限公司 (中国江苏省苏州市高新区竹园路209号4号楼25层2502-3) filed a patent application (PCT/CN2024/119712) for "PHARMACEUTICAL COMPOSITION CONTAINING TLR7/8 SELECTIVE AGONIST AND HBV CAPSID ASSEMBLY INHIBITOR AND USE THEREOF" on Sep 19, 2024. With publication no. WO/2025/061095, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application ...